XML 22 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Tables)
12 Months Ended
Dec. 31, 2011
Acquisitions  
Components and allocation of consideration transferred in connection with acquisitions completed in 2011

 

 

 
  Tribology   HPLC  

Consideration Transferred:

             

Cash paid

  $ 12.7   $ 1.1  

Stock issued

        2.9  

Cash acquired

    (0.2 )   (0.2 )
           

Total consideration transferred

  $ 12.5   $ 3.8  
           

Allocation of Consideration Transferred:

             

Accounts receivable

  $ 1.5   $ 0.2  

Inventory

    1.0     1.3  

Property, plant and equipment

        0.2  

Intangible assets:

             

Existing technology and related patents

    12.0     1.3  

Customer and distributor relationships

    0.6     1.5  

Tradename

        0.1  

In-process research and development

    0.1      

Goodwill

    3.5     1.2  

Liabilities assumed

    (6.2 )   (2.0 )
           

Total consideration transferred

  $ 12.5   $ 3.8  
           
Components and allocation of consideration transferred in connection with acquisitions completed in 2010

 

 

 
  Nano
Surfaces
  Chemical Analysis  

Consideration Transferred:

             

Cash paid

  $ 230.4   $ 37.5  
           

Total consideration transferred

  $ 230.4   $ 37.5  
           

Allocation of Consideration Transferred:

             

Accounts receivable

  $ 21.8   $  

Notes receivable

        10.3  

Inventory

    33.5     16.9  

Other current assets

    8.1      

Property, plant and equipment

    18.0     2.4  

Intangible assets:

             

Existing technology and related patents

    89.7     7.1  

Customer and distributor relationships

    1.5     15.8  

In-process research and development

    21.3      

Goodwill

    49.0     0.4  

Liabilities assumed

    (12.5 )   (15.4 )
           

Total consideration transferred

  $ 230.4   $ 37.5  
           
Schedule of pro forma financial information reflecting the acquisition of the nano surfaces business

 

 

 
  2010   2009  

Revenue

  $ 1,410.7   $ 1,211.8  

Net income attributable to Bruker Corporation

    97.0     55.3  

Net income per common share attributable to Bruker Corporation shareholders:

             

Basic and diluted

  $ 0.59   $ 0.34